BIOGEN INC (BIIB)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BIIB
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BIIB | Founding President & Chief Business Officer at Souffle Therapeutics | 35 | ["Executive Leadership and Business Operations","Commercial","Drug Development","Healthcare and Pharma Leadership","Significant experience and knowledge of the biopharmaceutical industry","Deep connections within the biotechnology, start-up and venture capital ecosystems"] | ["Compensation and Management Development"] | 2026 |
Biography sourced from the proxy statement filing.
Susan Langer, Founding President & Chief Business Officer at Souffle Therapeutics Director since 2023 Age 35 Board Committee Compensation and Management Development Key Skills Executive Leadership and Business Operations Commercial Drug Development Healthcare and Pharma Leadership Relevant Expertise Ms. Langer has significant experience and knowledge of the biopharmaceutical industry and deep connections within the biotechnology, start-up and venture capital ecosystems. That expertise, coupled with her knowledge of Biogen s operations, enhances the Board s ability to nimbly evaluate growth opportunities as well as long-term investments. Career Highlights Founding President and Chief Business Officer, Souffle Therapeutics (since 2021) Founding President, Kojin Therapeutics (2020 2021) Chief Business Officer, Paratus Sciences (2021 2023) Director, Guava Partners (since 2021) Venture Partner, Old Silver VC LLC (2020 2023) Head of Corporate Strategy and other roles at Biogen (2013 2019) Other Public Company Boards None Education B.A. in Science & Technology Studies from Cornell University